Current management of severe refractory asthma in Italy: analysis of real-world data
IntroductionSevere refractory asthma (SRA) occurs in asthma patients failing to achieve disease control despite high-intensity therapy, good adherence, and proper inhalation technique. Lack of disease control in asthma is associated with increased health care costs. Omalizumab, an anti-IgE monoclona...
Main Authors: | Antonella Pedrini, Elisa Rossi, Silvia Calabria, Letizia Dondi, Nello Martini |
---|---|
Format: | Article |
Language: | English |
Published: |
AboutScience Srl
2017-10-01
|
Series: | Global & Regional Health Technology Assessment |
Online Access: | http://www.grhta.com/Attach/34B984FB-82E7-43AB-8CD6-2B3C2E61DBF5/BD621B56-03C1-4B0A-876D-3759484FB2C3 |
Similar Items
-
by: Antonella Pedrini, et al.
Published: (2017-12-01) -
Burden of disease, healthcare pathways and costs of cardiovascular high-risk patients with type 2 diabetes: a real world analysis
by: Carlo Piccinni, et al.
Published: (2018-03-01) -
Metastatic renal cancer: real-world evidence from a large Italian claims database
by: Giulia Ronconi, et al.
Published: (2021-02-01) -
A real-world study on unmet medical needs in triptan-treated migraine: prevalence, preventive therapies and triptan use modification from a large Italian population along two years
by: Carlo Piccinni, et al.
Published: (2019-06-01) -
A Real-World Evaluation of Clinical Outcomes of Biologicals and Bronchial Thermoplasty for Severe Refractory Asthma (BIOTERM)
by: Menzella F, et al.
Published: (2021-08-01)